Telesis Bio, Inc. reported impairment charges for the fourth quarter ended December 31, 2023. For the quarter, the company reported goodwill impairment of $11,389,000.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3224 USD | -8.98% | +1.26% | -19.20% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.20% | 10.66M | |
+8.34% | 218B | |
+7.44% | 183B | |
+13.32% | 134B | |
+26.06% | 106B | |
-1.33% | 61.12B | |
+4.81% | 50.89B | |
+0.51% | 40.3B | |
+3.01% | 35.53B | |
+26.53% | 32.05B |
- Stock Market
- Equities
- TBIO Stock
- News Telesis Bio, Inc.
- Telesis Bio, Inc. Reports Impairment Charges for the Fourth Quarter Ended December 31, 2023